Aprepitant Capsules and Carbidopa and Levodopa Extended-Release Tablets
Determining the interaction of Aprepitant Capsules and Carbidopa and Levodopa Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Capsules-Carbidopa and Levodopa ODT
- Aprepitant Capsules-Carbidopa and Levodopa Orally Disintegrating Tablets
- Aprepitant Capsules-Carbidopa and levodopa Route Not Applicable
- Aprepitant Capsules-Carbidopa and Levodopa Tablets
- Aprepitant Capsules-Carbidopa Tablets
- Aprepitant Capsules-Carbidopa, entacapone, and levodopa
- Carbidopa and Levodopa Extended-Release Tablets-Aprepitant Injection
- Carbidopa and Levodopa Extended-Release Tablets-Aprepitant Intravenous
- Carbidopa and Levodopa Extended-Release Tablets-Aprepitant Oral Suspension
- Carbidopa and Levodopa Extended-Release Tablets-Aprepitant/Fosaprepitant Dimeglumine
- Carbidopa and Levodopa Extended-Release Tablets-Apresazide
- Carbidopa and Levodopa Extended-Release Tablets-Apresoline